Risankizumab shows promise for PsA in the KEEPsAKE 2 trial | Andrew Ostor

(3:39)

Risankizumab shows efficacy in improving plaque psoriasis

(1:8)

Using the SKYRIZI On-Body Injector | See Bit.ly/SkyriziPI

(17:40)

Study shows risankizumab is effective regardless of prior biologic treatment

(1:8)

How to Inject with the SKYRIZI Pen | See Bit.ly/SkyriziPI

(10:49)

Risankizumab for PsA: How will the KEEPsAKE 1 \u0026 2 findings impact clinical practice? | Laura Coates

(5:10)

Risankizumab for Ulcerative Colitis

(15:50)

Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis

(5:9)

Superior risankizumab efficacy vs. apremilast in systemic-eligible moderate psoriasis.

(6:12)

Risankizumab Safe, Effective in Moderate to Severe Crohn's Disease - Medpage Today

(10:2)

Brian Feagan, MD: Risankizumab for Crohn's Disease

(3:10)

How SKYRIZI Works | See Bit.ly/SkyriziPI

(5:30)

Risankizumab impresses in phase 2 psoriatic arthritis trial

(4:2)

Skyrizi (Risankizumab) - plaque psoriasis

(1:36)

Allen: A Plaque Psoriasis Patient | See Bit.ly/SkyriziPI

(5:52)

Amongst people w/ psoriasis, does exposure to Risankizumab ... (Yiu, SOS Challenge Presentation)

(10:43)

Ken Gordon, MD: Insights on Risankizumab for Plaque Psoriasis

(2:22)

The Skyrizi Complete App | See Bit.ly/SkyriziPI

(7:51)

Risankizumab worsened symptoms in patients with severe asthma, new study finds

(1:9)

How to Inject with the SKYRIZI Syringe | See Bit.ly/SkyriziPI

(10:10)